benefits of Ayurvedic enema in CKD

an open label control clinical study to evaluate the efficacy of trinpanchamool kwath siddha basti in Chronic kidney disease. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100050

Enrollment

Registered

2026-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N182- Chronic kidney disease, stage 2 (mild)

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of CKD or patients having clinical sign and symptoms of CKD Clinically stable patients of stage 1 to stage 3 Patients having Serum Creatinine level between 1.4mg/dl to = 5mg/dl Age group between 20- 65 yearS Patient fit for basti karma and willing to participate in clinical trial. Nondiabetic and if Diabetic- HbA1c in % less than 7.0

Exclusion criteria

Exclusion criteria: Stage: Patient of any stage requiring dialysis/ who is already on dialysis Patient with severe toxicity Patient with End stage renal disease (ESRD) Patient having poly cystic kidney or any other kidney disorder Patient with autoimmune or genetic disorder or carcinoma Pregnant female and lactating mother Patient having serious systemic disorders (like chronic heart disease etc) Patient with hypertension =150/100 mmHg

Design outcomes

Primary

Measure	Time frame
1 reducion in biomarkers (serum createnine, bloodurea and eGFR) of CKDTimepoint: 1 reducion in biomarkers (serum createnine, bloodurea and eGFR) of CKD 48 day	—

Secondary

Measure	Time frame
Efficacy of the trinpanchamool kwath siddha Basti in reduction of Subjective Parameters/symptomsTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDR ABHISHEK SAXENA

SHRI KRISHNA AYUSH UNIVERSITY KURUKSHETRA HARYANA

drashishhmehta@gmail.com8950375285

Outcome results